Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial).

Sumito SaekiShigehira SajiNorikazu MasudaHitoshi TsudaFutoshi AkiyamaMasafumi KurosumiAkihiko ShimomuraNobuaki SatoShintaro TakaoShozo OhsumiYutaka TokudaHideo InajiToru WatanabeYasuo Ohashi

Published in: Breast cancer research and treatment (2020)

This long-term follow-up study showed that RFS and OS were similar in patients with luminal-type breast cancer treated with CMF and UFT.

Keyphrases

end stage renal disease
study protocol
randomized controlled trial
newly diagnosed
clinical trial
phase iii
ejection fraction
chronic kidney disease
peritoneal dialysis
phase ii
prognostic factors
systematic review
patient reported outcomes
meta analyses